Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 379.10M | $ 257.90M | $ 201.40M | $ 197.90M | $ 242.60M |
Total Assets | $ 2.45B | $ 2.10B | $ 1.94B | $ 1.85B | $ 1.66B |
Total Debt | $ 375.80M | $ 299.90M | $ 285.90M | $ 321.00M | $ 358.80M |
Net Debt | $ -3.30M | $ 42.00M | $ 84.50M | $ 123.10M | $ 116.20M |
Total Liabilities | $ 1.16B | $ 992.70M | $ 960.50M | $ 947.70M | $ 903.70M |
Stockholders Equity | $ 1.29B | $ 1.11B | $ 974.50M | $ 899.40M | $ 754.20M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |